Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial

被引:8
作者
Billingy, Nicole E. [1 ]
Tromp, Vashti N. M. F. [2 ]
Aaronson, Neil K. [3 ]
Hoek, Rianne J. A. [1 ]
Bogaard, Harm Jan [1 ]
Onwuteaka-Philipsen, Bregje D. [4 ]
van de Poll-franse, Lonneke [3 ,5 ,6 ]
Hugtenburg, Jacqueline G. [2 ]
Belderbos, Jose [7 ]
Becker-Commissaris, Annemarie [1 ]
van den Hurk, Corina J. G. [5 ]
Walraven, Iris [8 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Amsterdam Publ Hlth Res Inst, Canc Ctr Amsterdam,Dept Pulm Dis, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Dept Clin Pharmacol & Pharm, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Canc Ctr Amsterdam, Dept Publ & Occupat Hlth, Amsterdam, Netherlands
[5] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[6] Tilburg Univ, CoRPS Ctr Res Psychol & Somat Disorders, Dept Med & Clin Psychol, Tilburg, Netherlands
[7] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[8] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2023年 / 115卷 / 12期
关键词
COMMON TERMINOLOGY CRITERIA; REPORTED OUTCOMES VERSION; EUROPEAN-ORGANIZATION; CANCER; MANAGEMENT; SURVIVAL; QLQ-C30; BURDEN;
D O I
10.1093/jnci/djad159
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Previous studies using patient-reported outcomes measures (PROMs) to monitor symptoms during and after (lung) cancer treatment used alerts that were sent to the health-care provider, although an approach in which patients receive alerts could be more clinically feasible. The primary aim of this study was to compare the effect of weekly PROM symptom monitoring via a reactive approach (patient receives alert) or active approach (health-care provider receives alert) with care as usual on health-related quality of life (HRQOL) at 15 weeks after start of treatment in lung cancer patients. Methods: The SYMPRO-Lung trial is a multicenter randomized controlled trial using a stepped wedge design. Stage I-IV lung cancer patients in the reactive and active groups reported PROM symptoms weekly, which were linked to a common alerting algorithm. HRQOL was measured by the EORTC QLQ-C30 at baseline and after 15 weeks. Linear regression analyses and effect size estimates were used to assess mean QOL-C30 change scores between groups, accounting for confounding. Results: A total of 515 patients were included (160 active group, 89 reactive group, 266 control group). No differences in HRQOL were observed between the reactive and active group (summary score: unstandardized beta [B] = 0.51, 95% confidence interval [CI] = -3.22 to 4.24, Cohen d effect size [ES] = 0.06; physical functioning: B = 0.25, 95% CI = -5.15 to 4.64, ES = 0.02). The combined intervention groups had statistically and clinically significantly better mean change scores on the summary score (B = 4.85, 95% CI = 1.96 to 7.73, ES = 0.57) and physical functioning (B = 7.00, 95% CI = 2.90 to 11.09, ES = 0.71) compared with the control group. Conclusions: Weekly PRO symptom monitoring statistically and clinically significantly improves HRQOL in lung cancer patients. The logistically less intensive, reactive approach may be a better fit for implementation.
引用
收藏
页码:1515 / 1525
页数:11
相关论文
共 32 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life
    Baratelli, Chiara
    Turco, Carmela Giovanna Cleopatra
    Lacidogna, Gaetano
    Sperti, Elisa
    Vignani, Francesca
    Marino, Donatella
    Zichi, Clizia
    De Luca, Emmanuele
    Audisio, Marco
    Ballaminut, Daniela
    Bellezza, Annalisa
    Chiotto, Paola
    Ciriolo, Giovanna
    Comite, Rossella
    Codegone, Fulvia
    Florio, Santina
    Fusco, Luisa
    Polimeno, Laura
    Pozzi, Donatella
    Zilio, Eliana
    Terzolo, Sabrina
    Di Maio, Massimo
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (12) : 4697 - 4704
  • [3] Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer A Randomized Clinical Trial
    Basch, Ethan
    Schrag, Deborah
    Henson, Sydney
    Jansen, Jennifer
    Ginos, Brenda
    Stover, Angela M.
    Carr, Philip
    Spears, Patricia A.
    Jonsson, Mattias
    Deal, Allison M.
    Bennett, Antonia, V
    Thanarajasingam, Gita
    Rogak, Lauren J.
    Reeve, Bryce B.
    Snyder, Claire
    Bruner, Deborah
    Cella, David
    Kottschade, Lisa A.
    Perlmutter, Jane
    Geoghegan, Cindy
    Samuel-Ryals, Cleo A.
    Given, Barbara
    Mazza, Gina L.
    Miller, Robert
    Strasser, Jon F.
    Zylla, Dylan M.
    Weiss, Anna
    Blinder, Victoria S.
    Dueck, Amylou C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (24): : 2413 - 2422
  • [4] Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
    Basch, Ethan
    Deal, Allison M.
    Kris, Mark G.
    Scher, Howard I.
    Hudis, Clifford A.
    Sabbatini, Paul
    Rogak, Lauren
    Bennett, Antonia V.
    Dueck, Amylou C.
    Atkinson, Thomas M.
    Chou, Joanne F.
    Dulko, Dorothy
    Sit, Laura
    Barz, Allison
    Novotny, Paul
    Fruscione, Michael
    Sloan, Jeff A.
    Schrag, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 557 - +
  • [5] Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Reeve, Bryce B.
    Mitchell, Sandra A.
    Clauser, Steven B.
    Minasian, Lori M.
    Dueck, Amylou C.
    Mendoza, Tito R.
    Hay, Jennifer
    Atkinson, Thomas M.
    Abernethy, Amy P.
    Bruner, Deborah W.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Chilukuri, Ram
    Baumgartner, Paul
    Denicoff, Andrea
    St Germain, Diane
    O'Mara, Ann M.
    Chen, Alice
    Kelaghan, Joseph
    Bennett, Antonia V.
    Sit, Laura
    Rogak, Lauren
    Barz, Allison
    Paul, Diane B.
    Schrag, Deborah
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09):
  • [6] Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
    Basch, Ethan
    Jia, Xiaoyu
    Heller, Glenn
    Barz, Allison
    Sit, Laura
    Fruscione, Michael
    Appawu, Mark
    Iasonos, Alexia
    Atkinson, Thomas
    Goldfarb, Shari
    Culkin, Ann
    Kris, Mark G.
    Schrag, Deborah
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23): : 1624 - 1632
  • [7] Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment.
    Basch, Ethan M.
    Deal, Allison Mary
    Dueck, Amylou C.
    Bennett, Antonia Vickery
    Atkinson, Thomas Michael
    Scher, Howard I.
    Kris, Mark G.
    Hudis, Clifford A.
    Sabbatini, Paul
    Dulko, Dorothy
    Rogak, Lauren J.
    Barz, Allison Emily
    Schrag, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18)
  • [8] SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial
    Billingy, Nicole E.
    Tromp, Vashti N. M. F.
    Veldhuijzen, Evalien
    Belderbos, Jose
    Aaronson, Neil K.
    Feldman, Esther
    Hoek, Rianne J. A.
    Bogaard, Harm-Jan
    Onwuteaka-Philipsen, Bregje D.
    van de Poll-franse, Lonneke
    Hugtenburg, Jacqueline G.
    van den Hurk, Corina J. G.
    Becker-Commissaris, Annemarie
    Walraven, Iris
    [J]. BMJ OPEN, 2021, 11 (09):
  • [9] Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207
  • [10] cancer gov, NAT CANC I NONS CELL